Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.

Wei Y, Zhang Y, Xu Z, Wang G, Zhou Y, Li H, Shi L, Naci H, Wagner AK, Guan X

Open source

DOI: 10.1016/j.lanwpc.2024.101055
Published: 2024 Apr
Container: The Lancet regional health. Western Pacific
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanwpc.2024.101055,
  title = {Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.},
  author = {Wei Y and Zhang Y and Xu Z and Wang G and Zhou Y and Li H and Shi L and Naci H and Wagner AK and Guan X},
  year = {2024},
  journal = {The Lancet regional health. Western Pacific},
  doi = {10.1016/j.lanwpc.2024.101055},
  url = {https://doi.org/10.1016/j.lanwpc.2024.101055}
}

RIS

TY  - JOUR
TI  - Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.
AU  - Wei Y
AU  - Zhang Y
AU  - Xu Z
AU  - Wang G
AU  - Zhou Y
AU  - Li H
AU  - Shi L
AU  - Naci H
AU  - Wagner AK
AU  - Guan X
PY  - 2024
JO  - The Lancet regional health. Western Pacific
DO  - 10.1016/j.lanwpc.2024.101055
UR  - https://doi.org/10.1016/j.lanwpc.2024.101055
ER  -

APA

Y, W., Y, Z., Z, X., G, W., Y, Z., H, L., L, S., H, N., AK, W., & X, G. (2024). Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.. The Lancet regional health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2024.101055

Source records

pubmed · retrieved 2026-09-25T18:05:58.282Z
europe-pmc · retrieved 2026-09-25T18:05:58.306Z
doaj · retrieved 2026-09-25T18:05:58.305Z